[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

TW200611705A - PDPK FA system and cancer - Google Patents

PDPK FA system and cancer

Info

Publication number
TW200611705A
TW200611705A TW093129954A TW93129954A TW200611705A TW 200611705 A TW200611705 A TW 200611705A TW 093129954 A TW093129954 A TW 093129954A TW 93129954 A TW93129954 A TW 93129954A TW 200611705 A TW200611705 A TW 200611705A
Authority
TW
Taiwan
Prior art keywords
pdpk
present
application
cancer
expression
Prior art date
Application number
TW093129954A
Other languages
Chinese (zh)
Inventor
Shiaw-Der Yang
Original Assignee
Shiaw-Der Yang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiaw-Der Yang filed Critical Shiaw-Der Yang
Priority to TW093129954A priority Critical patent/TW200611705A/en
Publication of TW200611705A publication Critical patent/TW200611705A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to the application of a multisubstrate/multifunctional proline-directed protein kinase FA (PDPK FA) that is highly expressed in cancerous tissue and cell lines. The cloned cDNA is a partial sequence of~1.0 kb fragment of PDPK FA cDNA. The present invention further encompasses PDPK FA peptides, fusion proteins, host cell expression system, PDPK FA antibodies, PDPK FA antisense molecule and compounds that modulate PDPK FA gene expression or PDPK FA activity, and the kit that detects the PDPK FA expression. The present invention also encompasses methods for application of PDPK FA such as prevention, diagnosis, disease monitoring, drug screening, new strategies and prognosis prediction of cancers, including but not limited to cancer.
TW093129954A 2004-10-04 2004-10-04 PDPK FA system and cancer TW200611705A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW093129954A TW200611705A (en) 2004-10-04 2004-10-04 PDPK FA system and cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW093129954A TW200611705A (en) 2004-10-04 2004-10-04 PDPK FA system and cancer

Publications (1)

Publication Number Publication Date
TW200611705A true TW200611705A (en) 2006-04-16

Family

ID=57807692

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093129954A TW200611705A (en) 2004-10-04 2004-10-04 PDPK FA system and cancer

Country Status (1)

Country Link
TW (1) TW200611705A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011026429A1 (en) * 2009-09-02 2011-03-10 National Tsing Hua University Methods and compositions for detection of lethal cell and uses thereof
CN103180455A (en) * 2010-07-22 2013-06-26 杨孝德 Yang shiaw-der
CN101899493B (en) * 2008-12-17 2017-04-12 国立清华大学 Detection of unhealthy cell and uses thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101899493B (en) * 2008-12-17 2017-04-12 国立清华大学 Detection of unhealthy cell and uses thereof
WO2011026429A1 (en) * 2009-09-02 2011-03-10 National Tsing Hua University Methods and compositions for detection of lethal cell and uses thereof
CN103180455A (en) * 2010-07-22 2013-06-26 杨孝德 Yang shiaw-der
TWI512294B (en) * 2010-07-22 2015-12-11 Nat Univ Tsing Hua Methods and compositions for detection of lethal system and uses thereof

Similar Documents

Publication Publication Date Title
WO2008105797A3 (en) Polynucleotides encoding novel pcsk9 variants
WO2005100998A3 (en) Membrane markers for use in cancer diagnosis and therapy
WO2001055307A3 (en) Nucleic acids, proteins, and antibodies
WO2004053079A3 (en) Compositions, splice variants and methods relating to ovarian specific genes and proteins
WO2005026317A3 (en) Polynucleotides encoding novel variants of the trp channel family member, ltrpc3
WO2002088750A3 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
Kim et al. Carboxypeptidase X-1 (CPX-1) is a secreted collagen-binding glycoprotein
WO2003105773A3 (en) Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic targets:
WO2002040672A3 (en) Compositions and methods relating to breast specific genes and proteins
WO2004012673A3 (en) Methods and reagents relating to inflammation and apoptosis
TW200611705A (en) PDPK FA system and cancer
MXPA03005436A (en) Polynucleotides encoding novel human phosphatases.
WO2002040673A3 (en) Compositions and methods relating to lung specific genes and proteins
IL207012A0 (en) Diagnosis and therapy of cancer using sgp28-related molecules
WO2003027231A3 (en) Polynucleotide encoding adapter protein, pmn29
WO2002077232A3 (en) Compositions and methods relating to breast specific genes and proteins
WO2004005487A3 (en) Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, bgs42
WO2004053075A3 (en) Compositions, splice variants and methods relating to breast specific genes and proteins
WO2005017102A3 (en) Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins
WO2004013311A3 (en) Compositions and methods relating to ovarian specific genes and proteins
WO2002090991A3 (en) Proteins and genes for diagnosis and treatment of erbb2-related cancer
WO2004035783A3 (en) Protein complexes of the tumor-necrosis-factor-alpha (tnf-alpha) signalling pathway
IL155687A0 (en) Polynucleotides encoding hlrrsi1 polypeptides
WO2002068645A8 (en) Compositions and methods relating to breast specific genes and proteins
WO2004052290A3 (en) Compositions, splice variants and methods relating to breast specific genes and proteins